Ferah Bulut
Elazig, 23119, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Humanin attenuates metabolic, toxic, and traumatic neuropathic pain in mice by protecting against oxidative stress and increasing inflammatory cytokine.
Journal: Neuropharmacology
Published: May 20, 2024
Humanin's impact on pain markers and neuronal viability in diabetic neuropathy model.
Journal: Archives of physiology and biochemistry
Published: April 10, 2024
Gadolinium-based contrast agents aggravate mechanical and thermal hyperalgesia in a nitroglycerine-induced migraine model in male mice.
Journal: Magnetic resonance imaging
Published: February 28, 2024
Modulation of Neuronal Damage in DRG by Asprosin in a High-Glucose Environment and Its Impact on miRNA181-a Expression in Diabetic DRG.
Journal: Neurotoxicity research
Published: May 18, 2023
Protective effects of chronic humanin treatment in mice with diabetic encephalopathy: A focus on oxidative stress, inflammation, and apoptosis.
Journal: Behavioural brain research
Published: April 25, 2023
Crosstalk between kisspeptin and gonadotropin-inhibitory hormone in the silence of puberty: preclinical evidence from a calcium signaling study.
Journal: Journal of receptor and signal transduction research
Published: September 22, 2022
Asprosin, a novel therapeutic candidate for painful neuropathy: an experimental study in mice.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: November 06, 2021
Asprosin, a novel glucogenic adipokine: a potential therapeutic implication in diabetes mellitus.
Journal: Archives of physiology and biochemistry
Published: March 05, 2021
Kisspeptin leads to calcium signaling in cultured rat dorsal root ganglion neurons.
Journal: General physiology and biophysics
Published: November 04, 2020
Last Updated: 09/26/2026